Related Experiment Video
Updated: Jul 7, 2026
13:48
Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
Published on: June 24, 2012
Norovirus gastroenteritis, increased understanding and future antiviral options
1Cincinnati Children's Hospital Medical Center, Division of Infectious Diseases, University of Cincinnati, Cincinnati, OH 45229-3039, USA.
Current Opinion in Investigational Drugs (London, England : 2000)
|February 5, 2008
Summary
Norovirus causes widespread gastroenteritis, posing control challenges due to a lack of vaccines or antivirals. Research advances offer new strategies for developing norovirus antiviral treatments.
Area of Science:
- Virology
- Infectious Diseases
- Gastroenterology
Background:
- Norovirus is a significant cause of acute gastroenteritis globally.
- Control is challenging due to its prevalence and lack of specific treatments like vaccines or antiviral agents.
- Despite cultivation difficulties, substantial progress has been made in understanding norovirus biology.
Purpose of the Study:
- To review recent advancements in norovirus gastroenteritis treatment strategies.
- To discuss emerging research directions for developing effective antiviral therapies against norovirus infections.
Main Methods:
- Literature review of recent scientific publications on norovirus.
- Analysis of studies focusing on viral structure, replication, and host interactions.
- Synthesis of information on potential antiviral targets and therapeutic approaches.
Main Results:
- Advances in understanding norovirus genomics, proteins, replication, and host interactions.
- Identification of potential therapeutic strategies targeting viral attachment, protease, polymerase, and replication.
- Emerging insights into virus-host interactions offer novel avenues for drug development.
Conclusions:
- New strategies for norovirus antiviral development are emerging from basic research.
- Targeting viral attachment, replication enzymes, and host interactions shows promise for future treatments.
- Continued research is crucial for developing effective interventions against norovirus gastroenteritis.
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:26Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...